OKYO Pharma OKYO
NASDAQ OKYO
$1.44 -0.10 (-6.49%)
As of: Oct 22, 2026 · 12:05 PM EDT

OKYO Pharma (OKYO) Change in Other Operating Liabilities (2026)

Updated

Analysis

OKYO Pharma (OKYO) Change in Other Operating Liabilities (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,170.57 Bn 1,139.16 Bn 19.71 Bn -
2 Johnson & Johnson 641.68 Bn 560.21 Bn 17.26 Bn -972.00 Mn
3 AbbVie 502.16 Bn 475.27 Bn 12.70 Bn -
4 Merck 375.54 Bn 329.92 Bn 12.21 Bn -
5 Novartis Ag 302.70 Bn 266.69 Bn 11.24 Bn -
6 Astrazeneca 268.54 Bn 242.22 Bn 12.86 Bn -
7 Amgen 242.61 Bn 198.01 Bn 7.24 Bn -32.00 Mn
8 Gilead Sciences 193.36 Bn 167.56 Bn 6.22 Bn -
9 Pfizer 172.54 Bn 119.18 Bn 10.94 Bn -112.00 Mn
10 OKYO Pharma 961.18 Mn 934.41 Mn - -1.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.50 Mn
API Access

OKYO Pharma Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=OKYO&period=max&api_key=YOUR_API_KEY